These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8728386)

  • 1. Additional anticoagulant strategies for managing heparin-induced thrombocytopenia.
    Nawarskas JJ; Spinler SA
    Am J Health Syst Pharm; 1996 Apr; 53(8):945. PubMed ID: 8728386
    [No Abstract]   [Full Text] [Related]  

  • 2. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
    Murphy GS; Marymont JH
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495
    [No Abstract]   [Full Text] [Related]  

  • 4. Hitting back HIT.
    Gude D
    Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
    [No Abstract]   [Full Text] [Related]  

  • 5. CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.
    Greinacher A
    N Engl J Med; 2015 Jul; 373(3):252-61. PubMed ID: 26176382
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 7. Hirudin in heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia.
    Elalamy I; Lecrubier C; Potevin F; Abdelouahed M; Bara L; Marie JP; Samama M
    Thromb Haemost; 1995 Nov; 74(5):1384-5. PubMed ID: 8607131
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulant].
    Mitome J; Yamamoto H
    Nihon Rinsho; 2004 May; 62 Suppl 5():368-73. PubMed ID: 15197947
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of heparin-induced thrombocytopenia during continuous renal replacement therapy.
    Davenport A
    Am J Kidney Dis; 1998 Oct; 32(4):E3. PubMed ID: 10074589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic but effective: the HIT-fondaparinux brain puzzler.
    Greinacher A
    J Thromb Haemost; 2011 Dec; 9(12):2386-8. PubMed ID: 21929685
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia and cardiovascular diseases.
    Das P; Ziada K; Steinhubl SR; Moliterno DJ; Hamdalla H; Jozic J; Mukherjee D
    Am Heart J; 2006 Jul; 152(1):19-26. PubMed ID: 16824828
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban: for a few selected patients.
    Prescrire Int; 2013 Feb; 22(135):33-5. PubMed ID: 23444494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin.
    Shapiro M; Cohen J; Inbal A; Singer P
    Isr Med Assoc J; 2009 Mar; 11(3):188-90. PubMed ID: 19544713
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin-induced thrombocytopaenia.
    Prince M; Wenham T
    Postgrad Med J; 2018 Aug; 94(1114):453-457. PubMed ID: 30126928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heparin-induced thrombocytopenia].
    Christoffersen C; Lethagen S; Gøtze JP
    Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombocytopenia due to heparin therapy. Use of danaparoid (Orgaran), 13 monocentric cases under authorization of temporary prescription (ATU)].
    Gindre L; de Maistre E; Perrin A; Lecompte T; Hoffman MA
    Therapie; 1997; 52(6):591-7. PubMed ID: 9734113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.